LUCERO ALVAREZ, YALDA CECILIA
Preferred name
LUCERO ALVAREZ, YALDA CECILIA
Main Affiliation
Email
y.lucero@udd.cl
ORCID
0000-0002-8654-7239
Scopus Author ID
6507615689
21 results
Now showing 1 - 10 of 21
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, 5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study(2021); ;Anne J. Lagomarcino ;Juan P. Torres; Nora Mamani20 1Scopus© Citations 6 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Fructose Malabsorption in Chilean Children Undergoing Fructose Breath Test at a Tertiary Hospital(2020) ;Francisco Alliende; ;Francisca Jaime ;Gloria RíosMaría E. Arancibia<jats:title>ABSTRACT</jats:title><jats:p>Fructose is a highly abundant carbohydrate in western diet and may induce bowel symptoms in children as in adults. The main objective of this study is to describe the frequency of fructose malabsorption (FM) in symptomatic patients 18 years or younger undergoing fructose breath test in a single tertiary center between 2013 and 2018, and to evaluate whether certain symptoms are related to positivity of the test. Out of 273 tests 183 (67%) were compatible with FM. The most frequent pretest symptom in the overall study population was bloating (83%), followed by abdominal pain (73%). Patients with positive test were younger than those with a negative test (median 5 vs 8 years, <jats:italic>P</jats:italic> < 0.001). In multivariate analysis, which included age, sex, and symptoms (diarrhea, abdominal pain, bloating, nausea), only age <6 years (odds ratio 2.93, 95% confidence interval 1.64–5.23) and absence of nausea (odds ratio = 3.32, 95% confidence interval 1.56–7.05) were associated with FM.</jats:p>Scopus© Citations 1 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Hidradenitis supurativa paradójica inducida por infliximab en un paciente con colitis ulcerosa(Elsevier BV, 2026-03) ;Josefina Gazmuri ;Sofía Gómez-Barris ;María Fernanda Echeverría ;Colomba Cofré1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Corrigendum to ‘Corrigendum Helicobacter pylori, clinical, laboratory and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: a case-control study’(2022); ;Anne J. Lagomarcino ;Juan P. Torres; Nora Mamani1 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prevalence of Cow’s Milk Allergy in Infants from an Urban, Low-Income Population in Chile: A Cohort Study(MDPI AG, 2025-05-29) ;Sylvia Cruchet ;María Eugenia Arancibia; ;Pamela MarchantLorena RodríguezBackground. Cow’s milk allergy (CMA) is one of the most common food allergies in infancy, with prevalence estimates of 0.5–7.5% in high-income countries. Data from low- and middle-income regions remain limited, and the predominant immune mechanism (IgE or non-IgE mediated) may vary across populations. Objective. We aimed to determine the prevalence and clinical characteristics of CMA in infants from an urban, low-income Chilean population. Methods. A prospective cohort study was conducted at Padre Hurtado Hospital in Santiago, Chile. Healthy term newborns were recruited and followed for up to 12 months. Sociodemographic, perinatal data and parental atopy were recorded. Parents were contacted monthly to screen for CMA symptoms. Infants with ≥two symptoms underwent clinical evaluation, a 4-week cow’s milk protein exclusion diet, and an open oral food challenge (OFC). Diagnosis followed international consensus guidelines. Results. Of 552 enrolled infants (48% male), 27 were diagnosed with CMA, yielding a prevalence of 4.9% (95% CI 3.1–7.0%). All cases exhibited non-IgE-mediated symptoms, including vomiting, dermatitis, colic, and perianal erythema. CMA was diagnosed before 6 months of age in 74% of cases. At 12 months, 40% had developed oral tolerance. Sociodemographic and perinatal characteristics were similar between groups, but some self-reported parental atopic traits were more frequent in CMA cases. Conclusions. CMA prevalence in this Chilean cohort was comparable to that reported in high-income countries, with a predominance of non-IgE-mediated forms. These findings support the need for standardized diagnostic protocols, including OFC, in diverse populations. Future studies should explore long-term outcomes and risk factors in non-IgE-mediated CMA.</jats:p>4 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Accuracy of a Genetic Test for the Diagnosis of Hypolactasia in Chilean Children: Comparison With the Breath Test(2016) ;Francisco Alliende; ;Karen Espinoza ;Daniela SchnettleVictoria Romero13 1Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Effect of
<i>Helicobacter pylori</i>
eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial(2021); ;Anne J. Lagomarcino ;Juan P. Torres; Nora Mamani1Scopus© Citations 9 1
- «
- 1 (current)
- 2
- 3
- »